Advertisement.

BHVN Projected Dividend Yield

Ord Shs/Biohaven Ltd ( NYSE : BHVN )

Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on developing treatments for immunology, neuroscience, and oncology. Its programs include Kv7 ion channel modulation for epilepsy and mood disorders, extracellular protein degradation for immunological diseases, TRPM3 antagonism for migraine and neuropathic pain, TYK2/JAK1 inhibition for neuroinflammatory disorders, glutamate modulation for OCD and SCA, myostatin inhibition for neuromuscular and metabolic diseases like SMA and obesity, and antibody recruiting, bispecific molecules, and ADCs for cancer. Troriluzole is a new chemical entity and tripeptide prodrug of riluzole.

21 YEAR PERFORMANCE RESULTS

BHVN Dividend History Detail
BHVN Dividend News
BHVN Competitors News

# of Shares: 0

Closing Price: 18.59

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000